Lisa Stoner
Vice President of Investor Relations
Replay available
Humana Inc. (NYSE: HUM) Q3 2025 earnings conference call, held 2025-11-05. Replay captured from the company's public earnings webcast.

Vice President of Investor Relations
President and Chief Executive Officer
Chief Financial Officer
Analyst, Barclays
President of Enterprise Growth
Analyst, Mizuho Securities
Analyst, Wolfe Research
Analyst, Bank of America
President, Insurance Segment
Analyst, Wells Fargo Securities
Analyst, RBC Capital Markets
Analyst, Nefron Research
Analyst, UBS
Analyst, Evercore ISI
Analyst, Goldman Sachs
Analyst, TD Cowan
Analyst, Guggenheim
Analyst, Bernstein
Analyst, Baird
Analyst, Learing Partners
Good day and thank you for standing by. Welcome to the Humana third quarter earnings call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you'll need to press star 1-1 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star 1-1 again. Please be advised that today's conference is being recorded. I'd now like to hand the conference over to Lisa Stoner, Vice President of Investor Relations. Please go ahead. Thank you and good morning. I hope everyone had a chance to review our press release and posted remarks, which are available on our website. We will begin this morning with brief remarks from Jim Recton, Humana's President and Chief Executive Officer, and Chief Financial Officer, Celeste Millay. Following these remarks, we will host a question and answer session where Jim and Celeste will be joined by George Ruttedon, President of the Insurance Segment, and David Dittenfoss, President of Enterprise Growth. Before we begin our discussion, I need to advise call participants of our cautionary statement. Certain of the matters discussed in this conference call are forward-looking and involve a number of risks and uncertainties. Actual results could differ materially. Investors are advised to read the detailed risk factors discussed in our latest Form 10-K, our other filings with the Securities and Exchange Commission, and our third quarter 2025 earnings press release as they relate to forward-looking statements along with other risks discussed in our SEC filings. We undertake no obligation to publicly address or update any forward-looking statements in future filings o...